Recursion Pharmaceuticals Ownership 2024 | Who Owns Recursion Pharmaceuticals Now?
Institutional Ownership
46.31%
Insider Ownership
4.56%
Retail Ownership
49.13%
Institutional Holders
142.00
Recursion Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 11.92% | 1.87% | 28,142,918 | 3,555,357 | 14.46% | 211,071,885 | Jun 30, 2024 |
| BAILLIE GIFFORD & CO | 11.27% | 0.16% | 26,589,936 | 2,522,132 | 10.48% | 199,424,521 | Jun 30, 2024 |
| VANGUARD GROUP INC | 9.13% | 0.00% | 21,556,546 | 5,541,782 | 34.60% | 161,674,096 | Jun 30, 2024 |
| BLACKROCK INC. | 7.33% | 0.00% | 17,310,162 | 4,989,127 | 40.49% | 129,826,217 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 6.52% | 1.53% | 15,384,615 | 15,384,615 | 100.00% | 115,384,613 | Jun 30, 2024 |
| MUBADALA INVESTMENT CO PJSC | 5.50% | 0.39% | 12,985,927 | - | - | 97,394,453 | Jun 30, 2024 |
| KINNEVIK AB (PUBL) | 5.04% | 100.00% | 11,905,668 | 1,500,000 | 14.42% | 89,292,510 | Jun 30, 2024 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 4.23% | 0.06% | 9,987,030 | -375,773 | -3.63% | 74,902,725 | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 4.21% | 0.86% | 9,934,491 | -428,312 | -4.13% | 74,309,993 | Jun 30, 2024 |
| STATE STREET CORP | 3.71% | 0.00% | 8,749,587 | -1,602,769 | -15.48% | 65,621,903,000 | Jun 30, 2024 |
| MIC CAPITAL MANAGEMENT UK LLP | 3.58% | 13.78% | 8,451,758 | - | - | 63,388,186 | Jun 30, 2024 |
| FMR LLC | 3.47% | 0.00% | 8,192,720 | -1,068,151 | -11.53% | 61,445,401 | Jun 30, 2024 |
| NVIDIA CORP | 3.27% | 14.70% | 7,706,363 | - | - | 57,797,723 | Jun 30, 2024 |
| DATA COLLECTIVE IV GP, LLC | 2.52% | 31.23% | 5,941,120 | - | - | 44,558,400 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.02% | 0.00% | 4,775,908 | 1,324,743 | 38.39% | 35,826,442 | Jun 30, 2024 |
| DCVC OPPORTUNITY FUND II GP, LLC | 1.67% | 44.95% | 3,951,141 | - | - | 29,633,558 | Jun 30, 2024 |
| EXOR CAPITAL LLP | 1.56% | 0.93% | 3,675,077 | 1,500,000 | 68.96% | 27,563,078 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 1.23% | 0.26% | 2,901,134 | 1,993,518 | 219.64% | 21,758,505 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.89% | 0.00% | 2,097,672 | 1,891,903 | 919.43% | 15,732,542 | Jun 30, 2024 |
| NORGES BANK | 0.83% | 0.00% | 1,947,295 | 1,947,295 | 100.00% | 14,604,713 | Jun 30, 2024 |
Recursion Pharmaceuticals's largest institutional shareholder is ARK INVESTMENT MANAGEMENT LLC, holding 11.92% of the company's total share outstanding, currently valued at $211.07M. The top 10 institutional shareholders own together 68.87% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| KINNEVIK AB (PUBL) | 5.04% | 100.00% | 11,905,668 | 1,500,000 | 14.42% | 89,292,510 | Jun 30, 2024 |
| DCVC OPPORTUNITY FUND II GP, LLC | 1.67% | 44.95% | 3,951,141 | - | - | 29,633,558 | Jun 30, 2024 |
| DATA COLLECTIVE IV GP, LLC | 2.52% | 31.23% | 5,941,120 | - | - | 44,558,400 | Jun 30, 2024 |
| NVIDIA CORP | 3.27% | 14.70% | 7,706,363 | - | - | 57,797,723 | Jun 30, 2024 |
| MIC CAPITAL MANAGEMENT UK LLP | 3.58% | 13.78% | 8,451,758 | - | - | 63,388,186 | Jun 30, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 11.92% | 1.87% | 28,142,918 | 3,555,357 | 14.46% | 211,071,885 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 6.52% | 1.53% | 15,384,615 | 15,384,615 | 100.00% | 115,384,613 | Jun 30, 2024 |
| COMMONS CAPITAL, LLC | 0.05% | 1.00% | 111,107 | 111,107 | 100.00% | 833,302 | Jun 30, 2024 |
| ELEVATUS WELATH MANAGEMENT | 0.15% | 0.96% | 342,567 | 312,917 | 1055.37% | 2,569,253 | Jun 30, 2024 |
| EXOR CAPITAL LLP | 1.56% | 0.93% | 3,675,077 | 1,500,000 | 68.96% | 27,563,078 | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 4.21% | 0.86% | 9,934,491 | -428,312 | -4.13% | 74,309,993 | Jun 30, 2024 |
| INSTITUTE FOR WEALTH MANAGEMENT, LLC. | 0.25% | 0.58% | 580,997 | -152 | -0.03% | 4,357,478 | Jun 30, 2024 |
| GHISALLO CAPITAL MANAGEMENT LLC | 0.47% | 0.58% | 1,100,000 | 1,100,000 | 100.00% | 8,250,000 | Jun 30, 2024 |
| CARROLL INVESTORS, INC | 0.03% | 0.42% | 80,766 | 66,967 | 485.30% | 605,745 | Jun 30, 2024 |
| MUBADALA INVESTMENT CO PJSC | 5.50% | 0.39% | 12,985,927 | - | - | 97,394,453 | Jun 30, 2024 |
| GREEN ALPHA ADVISORS, LLC | 0.03% | 0.38% | 62,999 | -9,435 | -13.03% | 472,492 | Jun 30, 2024 |
| CHERRY CREEK INVESTMENT ADVISORS, INC. | 0.04% | 0.37% | 93,338 | 35,782 | 62.17% | 700,035 | Jun 30, 2024 |
| MARATHON CAPITAL MANAGEMENT | 0.07% | 0.33% | 175,220 | 2,675 | 1.55% | 1,314,150 | Jun 30, 2024 |
| ALLEN OPERATIONS LLC | 0.09% | 0.32% | 217,657 | - | - | 1,632,428 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 0.12% | 0.28% | 290,000 | 290,000 | 100.00% | 2,175,000 | Jun 30, 2024 |
The largest Recursion Pharmaceuticals shareholder by % of total assets is KINNEVIK AB (PUBL). The company owns 11.91M shares of Recursion Pharmaceuticals (RXRX), representing 100.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 6.52% | 1.53% | 15,384,615 | 15,384,615 | 100.00% | 115,384,613 | Jun 30, 2024 |
| VANGUARD GROUP INC | 9.13% | 0.00% | 21,556,546 | 5,541,782 | 34.60% | 161,674,096 | Jun 30, 2024 |
| BLACKROCK INC. | 7.33% | 0.00% | 17,310,162 | 4,989,127 | 40.49% | 129,826,217 | Jun 30, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 11.92% | 1.87% | 28,142,918 | 3,555,357 | 14.46% | 211,071,885 | Jun 30, 2024 |
| BAILLIE GIFFORD & CO | 11.27% | 0.16% | 26,589,936 | 2,522,132 | 10.48% | 199,424,521 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 1.23% | 0.26% | 2,901,134 | 1,993,518 | 219.64% | 21,758,505 | Jun 30, 2024 |
| NORGES BANK | 0.83% | 0.00% | 1,947,295 | 1,947,295 | 100.00% | 14,604,713 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.89% | 0.00% | 2,097,672 | 1,891,903 | 919.43% | 15,732,542 | Jun 30, 2024 |
| EXOR CAPITAL LLP | 1.56% | 0.93% | 3,675,077 | 1,500,000 | 68.96% | 27,563,078 | Jun 30, 2024 |
| KINNEVIK AB (PUBL) | 5.04% | 100.00% | 11,905,668 | 1,500,000 | 14.42% | 89,292,510 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.02% | 0.00% | 4,775,908 | 1,324,743 | 38.39% | 35,826,442 | Jun 30, 2024 |
| GHISALLO CAPITAL MANAGEMENT LLC | 0.47% | 0.58% | 1,100,000 | 1,100,000 | 100.00% | 8,250,000 | Jun 30, 2024 |
| UBS GROUP AG | 0.70% | 0.00% | 1,649,050 | 976,619 | 145.24% | 12,367,876 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 0.33% | 0.14% | 769,230 | 769,230 | 100.00% | 5,769,225 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.28% | 0.05% | 664,450 | 664,450 | 100.00% | 4,983,375 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.60% | 0.02% | 1,426,242 | 529,762 | 59.09% | 10,696,815 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.20% | 0.03% | 483,595 | 483,595 | 100.00% | 3,626,963 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.70% | 0.00% | 1,651,754 | 438,742 | 36.17% | 12,388,155 | Jun 30, 2024 |
| NEUBERGER BERMAN GROUP LLC | 0.15% | 0.00% | 355,639 | 355,639 | 100.00% | 2,667,293 | Jun 30, 2024 |
| ELEVATUS WELATH MANAGEMENT | 0.15% | 0.96% | 342,567 | 312,917 | 1055.37% | 2,569,253 | Jun 30, 2024 |
As of Jun 30 2024, Recursion Pharmaceuticals's largest institutional buyer is RA CAPITAL MANAGEMENT, L.P.. The company purchased 15.38M stocks of RXRX, valued at $115.38M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STATE STREET CORP | 3.71% | 0.00% | 8,749,587 | -1,602,769 | -15.48% | 65,621,903,000 | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.17% | 0.12% | 395,673 | -1,404,796 | -78.02% | 2,967,548 | Jun 30, 2024 |
| FMR LLC | 3.47% | 0.00% | 8,192,720 | -1,068,151 | -11.53% | 61,445,401 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | - | - | - | -660,969 | -100.00% | - | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.19% | 0.01% | 444,244 | -445,995 | -50.10% | 3,331,830 | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 4.21% | 0.86% | 9,934,491 | -428,312 | -4.13% | 74,309,993 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -400,700 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -391,518 | -100.00% | - | Jun 30, 2024 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 4.23% | 0.06% | 9,987,030 | -375,773 | -3.63% | 74,902,725 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 0.01% | 0.00% | 35,439 | -362,215 | -91.09% | 265,793,000 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.04% | 0.00% | 94,854 | -282,871 | -74.89% | 711,405 | Jun 30, 2024 |
| NATIXIS | - | - | - | -272,598 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.75% | 0.00% | 1,768,312 | -195,465 | -9.95% | 13,262,352 | Jun 30, 2024 |
| STATE OF NEW JERSEY COMMON PENSION FUND D | - | - | - | -188,897 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.81% | 0.00% | 1,920,177 | -174,823 | -8.34% | 14,402,075 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -131,849 | -100.00% | - | Jun 30, 2024 |
| VESTMARK ADVISORY SOLUTIONS, INC. | 0.33% | 0.25% | 784,897 | -115,122 | -12.79% | 5,886,728 | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | - | - | - | -97,000 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | 0.00% | 6,875 | -90,669 | -92.95% | 52,078 | Jun 30, 2024 |
| TB ALTERNATIVE ASSETS LTD. | - | - | - | -70,800 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Recursion Pharmaceuticals's biggest institutional seller is STATE STREET CORP. The company sold -1.60M shares of RXRX, valued at $65.62B.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 6.52% | 1.53% | 15,384,615 | 15,384,615 | 100.00% | 115,384,613 | Jun 30, 2024 |
| NORGES BANK | 0.83% | 0.00% | 1,947,295 | 1,947,295 | 100.00% | 14,604,713 | Jun 30, 2024 |
| GHISALLO CAPITAL MANAGEMENT LLC | 0.47% | 0.58% | 1,100,000 | 1,100,000 | 100.00% | 8,250,000 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 0.33% | 0.14% | 769,230 | 769,230 | 100.00% | 5,769,225 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.28% | 0.05% | 664,450 | 664,450 | 100.00% | 4,983,375 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.20% | 0.03% | 483,595 | 483,595 | 100.00% | 3,626,963 | Jun 30, 2024 |
| NEUBERGER BERMAN GROUP LLC | 0.15% | 0.00% | 355,639 | 355,639 | 100.00% | 2,667,293 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 0.12% | 0.28% | 290,000 | 290,000 | 100.00% | 2,175,000 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.10% | 0.00% | 245,210 | 245,210 | 100.00% | 1,839,075 | Jun 30, 2024 |
| SCIENTECH RESEARCH LLC | 0.06% | 0.22% | 140,295 | 140,295 | 100.00% | 1,052,213 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.05% | 0.00% | 124,841 | 124,841 | 100.00% | 936,308,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 111,210 | 111,210 | 100.00% | 834,075 | Jun 30, 2024 |
| COMMONS CAPITAL, LLC | 0.05% | 1.00% | 111,107 | 111,107 | 100.00% | 833,302 | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | 0.04% | 0.01% | 93,500 | 93,500 | 100.00% | 701,250 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 84,941 | 84,941 | 100.00% | 638,182 | Jun 30, 2024 |
| HB WEALTH MANAGEMENT, LLC | 0.03% | 0.01% | 80,085 | 80,085 | 100.00% | 600,638 | Jun 30, 2024 |
| CITO CAPITAL GROUP, LLC | 0.03% | 0.22% | 77,000 | 77,000 | 100.00% | 578,000 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.03% | 0.08% | 63,274 | 63,274 | 100.00% | 474,555 | Jun 30, 2024 |
| BARCLAYS PLC | 0.03% | 0.00% | 60,000 | 60,000 | 100.00% | 450,000 | Jun 30, 2024 |
| HARBOUR CAPITAL ADVISORS, LLC | 0.02% | 0.10% | 55,025 | 55,025 | 100.00% | 410,487 | Jun 30, 2024 |
| PRIVIUM FUND MANAGEMENT B.V. | 0.02% | 0.10% | 52,000 | 52,000 | 100.00% | 372,320 | Jun 30, 2024 |
| HOYLECOHEN, LLC | 0.02% | 0.03% | 45,522 | 45,522 | 100.00% | 341,415 | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | 0.02% | 0.04% | 42,400 | 42,400 | 100.00% | 318,000 | Jun 30, 2024 |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 0.02% | 0.03% | 40,251 | 40,251 | 100.00% | 301,883 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.01% | 0.04% | 33,458 | 33,458 | 100.00% | 250,935 | Jun 30, 2024 |
| DNB ASSET MANAGEMENT AS | 0.01% | 0.00% | 33,119 | 33,119 | 100.00% | 248,061 | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.01% | 0.00% | 32,755 | 32,755 | 100.00% | 245,663 | Jun 30, 2024 |
| MAN GROUP PLC | 0.01% | 0.00% | 27,971 | 27,971 | 100.00% | 209,783 | Jun 30, 2024 |
| ZUCKERMAN INVESTMENT GROUP, LLC | 0.01% | 0.02% | 25,000 | 25,000 | 100.00% | 187,500 | Jun 30, 2024 |
| PIER 88 INVESTMENT PARTNERS LLC | 0.01% | 0.04% | 24,700 | 24,700 | 100.00% | 185,250 | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | 0.01% | 0.02% | 23,092 | 23,092 | 100.00% | 173,190 | Jun 30, 2024 |
| STEEL PEAK WEALTH MANAGEMENT LLC | 0.01% | 0.01% | 21,532 | 21,532 | 100.00% | 161,490 | Jun 30, 2024 |
| 180 WEALTH ADVISORS, LLC | 0.01% | 0.02% | 17,455 | 17,455 | 100.00% | 134,054 | Jun 30, 2024 |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 0.01% | 0.00% | 17,217 | 17,217 | 100.00% | 129,000 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.01% | 0.00% | 17,158 | 17,158 | 100.00% | 129,000 | Jun 30, 2024 |
| MOSLEY WEALTH MANAGEMENT | 0.01% | 0.09% | 14,746 | 14,746 | 100.00% | 110,595 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.01% | 0.06% | 14,092 | 14,092 | 100.00% | 105,690 | Jun 30, 2024 |
| GILMAN HILL ASSET MANAGEMENT, LLC | 0.01% | 0.02% | 13,500 | 13,500 | 100.00% | 101,250 | Jun 30, 2024 |
| XPONANCE, INC. | 0.01% | 0.00% | 13,132 | 13,132 | 100.00% | 98,490 | Jun 30, 2024 |
| MIDWEST FINANCIAL GROUP LLC | 0.01% | 0.06% | 12,019 | 12,019 | 100.00% | 90,000 | Jun 30, 2024 |
| PRIVATE ADVISOR GROUP, LLC | 0.01% | 0.00% | 11,987 | 11,987 | 100.00% | 89,904 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 0.01% | - | 11,936 | 11,936 | 100.00% | 89,520 | Jun 30, 2024 |
| PRIME CAPITAL INVESTMENT ADVISORS, LLC | 0.00% | 0.00% | 10,178 | 10,178 | 100.00% | 76,335 | Jun 30, 2024 |
| CI INVESTMENTS INC. | 0.00% | 0.00% | 6,052 | 6,052 | 100.00% | 45,000 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.00% | - | 6,000 | 6,000 | 100.00% | 164 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.00% | 0.01% | 2,500 | 2,500 | 100.00% | 18,750 | Jun 30, 2024 |
| JTC EMPLOYER SOLUTIONS TRUSTEE LTD | 0.00% | 0.00% | 2,392 | 2,392 | 100.00% | 18,000 | Jun 30, 2024 |
| HB WEALTH MANAGEMENT, LLC | 0.00% | 0.00% | 2,000 | 2,000 | 100.00% | 15,000 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 1,920 | 1,920 | 100.00% | 14,400 | Jun 30, 2024 |
| NBC SECURITIES, INC. | 0.00% | 0.00% | 1,710 | 1,710 | 100.00% | 12,000 | Jun 30, 2024 |
| SANDIA INVESTMENT MANAGEMENT LP | 0.00% | 0.01% | 1,000 | 1,000 | 100.00% | 7,500 | Jun 30, 2024 |
| CLOSE ASSET MANAGEMENT LTD | 0.00% | 0.00% | 800 | 800 | 100.00% | 6,000 | Jun 30, 2024 |
| MORTON BROWN FAMILY WEALTH, LLC | 0.00% | 0.00% | 400 | 400 | 100.00% | 3,148 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 355 | 355 | 100.00% | 2,663 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 221 | 221 | 100.00% | 1,658 | Jun 30, 2024 |
| DELTA ASSET MANAGEMENT LLC/TN | 0.00% | 0.00% | 200 | 200 | 100.00% | 1,500 | Jun 30, 2024 |
| COLONIAL TRUST ADVISORS | 0.00% | 0.00% | 200 | 200 | 100.00% | 1,500 | Jun 30, 2024 |
| FINANCIAL NETWORK WEALTH ADVISORS LLC | 0.00% | 0.00% | 200 | 200 | 100.00% | 1,500 | Jun 30, 2024 |
| TRIAD WEALTH PARTNERS, LLC | 0.00% | 0.00% | 153 | 153 | 100.00% | 1,148 | Jun 30, 2024 |
| QUARRY LP | 0.00% | 0.00% | 138 | 138 | 100.00% | 1,035 | Jun 30, 2024 |
| FORTITUDE FAMILY OFFICE, LLC | - | 0.00% | 81 | 81 | 100.00% | 608 | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | 64 | 64 | 100.00% | 525 | Jun 30, 2024 |
| RONALD BLUE TRUST, INC. | - | - | 33 | 33 | 100.00% | 329 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | - | - | 20 | 20 | 100.00% | 151 | Jun 30, 2024 |
| GRADIENT INVESTMENTS LLC | - | - | 15 | 15 | 100.00% | 113 | Jun 30, 2024 |
| PLANNING CAPITAL MANAGEMENT CORP | - | - | 8 | 8 | 100.00% | 60 | Jun 30, 2024 |
Recursion Pharmaceuticals's largest new institutional shareholder by number of shares is RA CAPITAL MANAGEMENT, L.P., purchased 15.38M shares, valued at $115.38M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | - | - | - | -660,969 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -400,700 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -391,518 | -100.00% | - | Jun 30, 2024 |
| NATIXIS | - | - | - | -272,598 | -100.00% | - | Jun 30, 2024 |
| STATE OF NEW JERSEY COMMON PENSION FUND D | - | - | - | -188,897 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -131,849 | -100.00% | - | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | - | - | - | -97,000 | -100.00% | - | Jun 30, 2024 |
| TB ALTERNATIVE ASSETS LTD. | - | - | - | -70,800 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -68,660 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -61,963 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -61,689 | -100.00% | - | Jun 30, 2024 |
| MONEY CONCEPTS CAPITAL CORP | - | - | - | -37,842 | -100.00% | - | Jun 30, 2024 |
| EDGESTREAM PARTNERS, L.P. | - | - | - | -35,105 | -100.00% | - | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | - | - | - | -32,812 | -100.00% | - | Jun 30, 2024 |
| JANNEY MONTGOMERY SCOTT LLC | - | - | - | -31,095 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -30,920 | -100.00% | - | Jun 30, 2024 |
| BLUESHIFT ASSET MANAGEMENT, LLC | - | - | - | -26,057 | -100.00% | - | Jun 30, 2024 |
| MARTINGALE ASSET MANAGEMENT L P | - | - | - | -25,313 | -100.00% | - | Jun 30, 2024 |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | - | - | - | -21,246 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -21,096 | -100.00% | - | Jun 30, 2024 |
| BRIDGEFRONT CAPITAL, LLC | - | - | - | -17,551 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -16,100 | -100.00% | - | Jun 30, 2024 |
| SYMMETRY PEAK MANAGEMENT LLC | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
| WEALTH EFFECTS LLC | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | - | - | - | -14,985 | -100.00% | - | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | - | - | - | -14,500 | -100.00% | - | Jun 30, 2024 |
| MOORS & CABOT, INC. | - | - | - | -13,500 | -100.00% | - | Jun 30, 2024 |
| STRATOS WEALTH PARTNERS, LTD. | - | - | - | -13,436 | -100.00% | - | Jun 30, 2024 |
| SENDER CO & PARTNERS, INC. | - | - | - | -12,934 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -12,334 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -11,077 | -100.00% | - | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -10,333 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -10,110 | -100.00% | - | Jun 30, 2024 |
| BALDWIN BROTHERS LLC/MA | - | - | - | -7,336 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -7,290 | -100.00% | - | Jun 30, 2024 |
| TUCKER ASSET MANAGEMENT LLC | - | - | - | -3,091 | -100.00% | - | Jun 30, 2024 |
| SMITHFIELD TRUST CO | - | - | - | -1,099 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -789 | -100.00% | - | Jun 30, 2024 |
| CAPITAL ADVISORS, LTD. LLC | - | - | - | -704 | -100.00% | - | Jun 30, 2024 |
| SANDY SPRING BANK | - | - | - | -650 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -314 | -100.00% | - | Jun 30, 2024 |
| FIRST COMMAND ADVISORY SERVICES, INC. | - | - | - | -70 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -28 | -100.00% | - | Jun 30, 2024 |
| CORECAP ADVISORS, LLC | - | - | - | -26 | -100.00% | - | Jun 30, 2024 |
| HOUSEHOLDER GROUP ESTATE & RETIREMENT SPECIALIST, LLC | - | - | - | -11 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
Recursion Pharmaceuticals's largest sold out institutional shareholder by shares sold is VOLORIDGE INVESTMENT MANAGEMENT, LLC, sold -0.66M shares, valued at -, as of undefined.
Recursion Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Ark ETF Trust | 2.68% | 21,491,159 | 14,007,177 | 187.16% | Jan 31, 2024 |
| Ark Venture Fund | 0.46% | 44,310 | 26,830 | 153.49% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.23% | 117,802 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.10% | 375,830 | 126,653 | 50.83% | Jan 31, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.09% | 10,821 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.09% | 2,477,381 | -115,331 | -4.45% | Feb 29, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.08% | 159,013 | - | - | Feb 29, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.07% | 12,505 | - | - | Mar 28, 2024 |
| Humankind Benefit Corp | 0.06% | 1,335 | 247 | 22.70% | Dec 31, 2023 |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0.05% | 380,143 | - | - | Mar 31, 2024 |
| FIDELITY CONTRAFUND | 0.05% | 3,546,342 | -828,686 | -18.94% | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.05% | 138,040 | - | - | Mar 31, 2024 |
| MFS SERIES TRUST I | 0.05% | 919,677 | - | - | Feb 29, 2024 |
| AB CAP FUND, INC. | 0.05% | 1,569,548 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.04% | 243,824 | -4,676 | -1.88% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.04% | 20,788 | -193 | -0.92% | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.03% | 14,221,468 | -2,152,843 | -13.15% | Mar 31, 2024 |
| Vericimetry Funds | 0.03% | 2,760 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.03% | 6,799 | -176 | -2.52% | Mar 31, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.03% | 75,388 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.03% | 308,249 | -65,407 | -17.50% | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.02% | 200,000 | - | - | Jan 31, 2024 |
| Nushares ETF Trust | 0.02% | 171,893 | 8,800 | 5.40% | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 67,209 | 1,085 | 1.64% | Feb 29, 2024 |
| WESMARK FUNDS | 0.02% | 65,200 | 65,200 | - | Mar 31, 2024 |
| ACAP Strategic Fund | 0.02% | 248,587 | - | - | Mar 31, 2024 |
| Bernstein Fund Inc | 0.02% | 145,540 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.02% | 4,106,578 | 54,787 | 1.35% | Feb 29, 2024 |
| Starboard Investment Trust | 0.01% | 7,900 | - | - | Feb 29, 2024 |
| ALPS ETF Trust | 0.01% | 149,552 | - | - | Feb 29, 2024 |
| Voya EQUITY TRUST | 0.01% | 17,275 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.01% | 28,000 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 386,817 | -346 | -0.09% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,509,381 | 45,034 | 3.08% | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.01% | 1,046,841 | 179,430 | 20.69% | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 581,075 | - | - | Jan 31, 2024 |
| Ultimus Managers Trust | 0.01% | 71,741 | - | - | Feb 29, 2024 |
| ETFis Series Trust I | 0.01% | 8,611 | -1,421 | -14.16% | Jan 31, 2024 |
| MFS VARIABLE INSURANCE TRUST | 0.01% | 183,308 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.01% | 13,560 | - | - | Mar 31, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 22,537 | - | - | Mar 31, 2024 |
| BAILLIE GIFFORD FUNDS | 0.00% | 48,012 | -2,265 | -4.51% | Mar 28, 2024 |
| ProFunds | 0.00% | 42,688 | -15,049 | -26.06% | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 22,076 | 12,569 | 132.21% | Aug 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 100,977 | -8,065 | -7.40% | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 140,000 | - | - | Feb 29, 2024 |
| NEW COVENANT FUNDS | 0.00% | 11,559 | - | - | Dec 31, 2023 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 149,900 | - | - | Feb 29, 2024 |
| Investment Managers Series Trust II | 0.00% | 26,859 | 26,859 | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 24,092 | -1,982 | -7.60% | Mar 31, 2024 |
| BARON SELECT FUNDS | 0.00% | 17,237 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 66,042 | - | - | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 827,759 | 34,401 | 4.34% | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 624,597 | 129,350 | 26.12% | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 44,892 | -9,800 | -17.92% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 31,222 | 901 | 2.97% | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 1,389,323 | 434,988 | 45.58% | Jan 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 73,335 | 47,804 | 187.24% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 6,464 | -331 | -4.87% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 21,824 | -252 | -1.14% | Mar 31, 2024 |
| MORGAN STANLEY INSTITUTIONAL FUND INC | 0.00% | 74,685 | -60,974 | -44.95% | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.00% | 20,000 | - | - | Jan 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 24,445 | 16,301 | 200.16% | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 19,247 | 3,084 | 19.08% | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 2,378 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 49,200 | 2,700 | 5.81% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 49,166 | 48 | 0.10% | Jan 31, 2024 |
| BlackRock ETF Trust | 0.00% | 405 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 59,284 | 561 | 0.96% | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 6,048,295 | -226,405 | -3.61% | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 7,184 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 40,563 | 12,765 | 45.92% | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 39,080 | 39,080 | - | Mar 28, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 1,678 | - | - | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 3,299 | - | - | Jan 31, 2024 |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0.00% | 13,929 | -16,122 | -53.65% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 382,048 | -15,417 | -3.88% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 599,511 | 64,049 | 11.96% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 1,245 | - | - | Dec 31, 2023 |
| Trust for Advised Portfolios | 0.00% | 5,779 | - | - | Dec 31, 2023 |
| Tidal ETF Trust | 0.00% | 3,545 | - | - | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 23,354 | 11,937 | 104.55% | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 1,343 | - | - | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 93,846 | 8,559 | 10.04% | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 761 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 52,375 | -212 | -0.40% | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 6,915,000 | -2,191,571 | -24.07% | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 184,102 | 120,580 | 189.82% | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 22,069 | 591 | 2.75% | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 47,292 | -28,879 | -37.91% | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 10,123 | - | - | Feb 29, 2024 |
| FLEXSHARES TRUST | 0.00% | 11,952 | -2,498 | -17.29% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 617 | - | - | Dec 31, 2023 |
| JPMORGAN TRUST II | 0.00% | 159,144 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 4,300 | -400 | -8.51% | Mar 28, 2024 |
| WisdomTree Trust | 0.00% | 304,621 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 35,558 | 4,911 | 16.02% | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 18,157 | -3,153 | -14.80% | Jan 31, 2024 |
| Pacer Funds Trust | 0.00% | 5,606 | 3,198 | 132.81% | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 48,901 | 48,901 | - | Feb 29, 2024 |
Recursion Pharmaceuticals's largest mutual fund holder by % of total assets is "Ark ETF Trust", owning 21.49M shares, compromising 2.68% of its total assets.
Recursion Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 142 | -44.53% |
| 31 Mar, 24 | 256 | 26.11% |
| 31 Dec, 23 | 203 | 2.53% |
| 30 Sep, 23 | 198 | 25.32% |
| 30 Jun, 23 | 158 | -1.25% |
| 31 Mar, 23 | 160 | 9.59% |
| 31 Dec, 22 | 146 | 1.39% |
| 30 Sep, 22 | 144 | 6.67% |
| 30 Jun, 22 | 135 | 6.30% |
| 31 Mar, 22 | 127 | - |
| 31 Dec, 21 | 127 | 41.11% |
| 30 Sep, 21 | 90 | 16.88% |
| 30 Jun, 21 | 77 | - |
As of 30 Jun 24, 142 institutions are holding Recursion Pharmaceuticals's shares, representing a decrease of -44.53% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 109,310,693 | -47.88% |
| 31 Mar, 24 | 209,712,724 | 1.57% |
| 31 Dec, 23 | 206,475,252 | 38.83% |
| 30 Sep, 23 | 148,726,778 | 19.33% |
| 30 Jun, 23 | 124,631,696 | -1.18% |
| 31 Mar, 23 | 126,120,204 | 1.96% |
| 31 Dec, 22 | 123,700,303 | 8.83% |
| 30 Sep, 22 | 113,663,971 | 6.80% |
| 30 Jun, 22 | 106,430,923 | 12.02% |
| 31 Mar, 22 | 95,011,263 | 0.70% |
| 31 Dec, 21 | 94,347,171 | 71.69% |
| 30 Sep, 21 | 54,952,866 | 16.99% |
| 30 Jun, 21 | 46,974,235 | - |
Recursion Pharmaceuticals (RXRX) has 109.31M shares outstanding as of 30 Jun 24, down -47.88% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 46.31% | 0.59% |
| 31 Mar, 24 | 88.85% | 1.13% |
| 31 Dec, 23 | 88.56% | 1.84% |
| 30 Sep, 23 | 69.39% | 1.81% |
| 30 Jun, 23 | 61.88% | 1.43% |
| 31 Mar, 23 | 65.82% | 1.48% |
| 31 Dec, 22 | 66.62% | 1.55% |
| 30 Sep, 22 | 65.54% | 1.72% |
| 30 Jun, 22 | 61.80% | 1.99% |
| 31 Mar, 22 | 55.66% | 1.81% |
| 31 Dec, 21 | 55.41% | 5.21% |
| 30 Sep, 21 | 32.61% | 2.83% |
| 30 Jun, 21 | 33.95% | - |
As of 30 Jun 24, Recursion Pharmaceuticals is held by 46.31% institutional shareholders, representing a 0.59% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 92 | -41.40% |
| 31 Mar, 24 | 157 | 38.94% |
| 31 Dec, 23 | 113 | -13.08% |
| 30 Sep, 23 | 130 | 54.76% |
| 30 Jun, 23 | 84 | 1.20% |
| 31 Mar, 23 | 83 | - |
| 31 Dec, 22 | 83 | -1.19% |
| 30 Sep, 22 | 84 | 15.07% |
| 30 Jun, 22 | 73 | 15.87% |
| 31 Mar, 22 | 63 | -38.24% |
| 31 Dec, 21 | 102 | 67.21% |
| 30 Sep, 21 | 61 | -20.78% |
| 30 Jun, 21 | 77 | - |
92 institutional shareholders have increased their position in RXRX stock as of 30 Jun 24 compared to 157 in the previous quarter (a -41.40% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 27 | -48.08% |
| 31 Mar, 24 | 52 | 15.56% |
| 31 Dec, 23 | 45 | 25.00% |
| 30 Sep, 23 | 36 | -12.20% |
| 30 Jun, 23 | 41 | 24.24% |
| 31 Mar, 23 | 33 | 13.79% |
| 31 Dec, 22 | 29 | 3.57% |
| 30 Sep, 22 | 28 | -12.50% |
| 30 Jun, 22 | 32 | -8.57% |
| 31 Mar, 22 | 35 | 218.18% |
| 31 Dec, 21 | 11 | -15.38% |
| 30 Sep, 21 | 13 | - |
| 30 Jun, 21 | - | - |
27 institutional shareholders have reduced their position in RXRX stock as of 30 Jun 24 compared to 52 in the previous quarter (a -48.08% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 142 | -44.53% | 109,310,693 | -47.88% | 46.31% | 0.59% | 92 | -41.40% | 27 | -48.08% |
| 31 Mar, 24 | 256 | 26.11% | 209,712,724 | 1.57% | 88.85% | 1.13% | 157 | 38.94% | 52 | 15.56% |
| 31 Dec, 23 | 203 | 2.53% | 206,475,252 | 38.83% | 88.56% | 1.84% | 113 | -13.08% | 45 | 25.00% |
| 30 Sep, 23 | 198 | 25.32% | 148,726,778 | 19.33% | 69.39% | 1.81% | 130 | 54.76% | 36 | -12.20% |
| 30 Jun, 23 | 158 | -1.25% | 124,631,696 | -1.18% | 61.88% | 1.43% | 84 | 1.20% | 41 | 24.24% |
| 31 Mar, 23 | 160 | 9.59% | 126,120,204 | 1.96% | 65.82% | 1.48% | 83 | - | 33 | 13.79% |
| 31 Dec, 22 | 146 | 1.39% | 123,700,303 | 8.83% | 66.62% | 1.55% | 83 | -1.19% | 29 | 3.57% |
| 30 Sep, 22 | 144 | 6.67% | 113,663,971 | 6.80% | 65.54% | 1.72% | 84 | 15.07% | 28 | -12.50% |
| 30 Jun, 22 | 135 | 6.30% | 106,430,923 | 12.02% | 61.80% | 1.99% | 73 | 15.87% | 32 | -8.57% |
| 31 Mar, 22 | 127 | - | 95,011,263 | 0.70% | 55.66% | 1.81% | 63 | -38.24% | 35 | 218.18% |
| 31 Dec, 21 | 127 | 41.11% | 94,347,171 | 71.69% | 55.41% | 5.21% | 102 | 67.21% | 11 | -15.38% |
| 30 Sep, 21 | 90 | 16.88% | 54,952,866 | 16.99% | 32.61% | 2.83% | 61 | -20.78% | 13 | - |
| 30 Jun, 21 | 77 | - | 46,974,235 | - | 33.95% | - | 77 | - | - | - |
Recursion Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Recursion Pharmaceuticals's stock was made by Secora Michael on Aug 15 2024, selling 15,000 shares at $6.35 per share (valued at $95.25K).
Recursion Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 14 | 22 | 63.64% |
| Q2 2024 | 25 | 41 | 60.98% |
| Q1 2024 | 39 | 68 | 57.35% |
| Q4 2023 | 24 | 55 | 43.64% |
| Q3 2023 | 30 | 90 | 33.33% |
| Q2 2023 | 32 | 45 | 71.11% |
| Q1 2023 | 59 | 60 | 98.33% |
| Q4 2022 | 30 | 50 | 60.00% |
| Q3 2022 | 11 | 22 | 50.00% |
| Q2 2022 | 21 | 36 | 58.33% |
| Q1 2022 | 42 | 25 | 168.00% |
| Q4 2021 | 13 | 34 | 38.24% |
| Q3 2021 | 6 | - | - |
| Q2 2021 | 72 | 76 | 94.74% |
14 total buy trades, and 22 total sell trades (buy/sell ratio of 0.64%) were made by Recursion Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 12 | - |
| Q2 2024 | - | 22 | - |
| Q1 2024 | - | 33 | - |
| Q4 2023 | - | 27 | - |
| Q3 2023 | - | 55 | - |
| Q2 2023 | - | 21 | - |
| Q1 2023 | 22 | 26 | 84.62% |
| Q4 2022 | 5 | 18 | 27.78% |
| Q3 2022 | - | 7 | - |
| Q2 2022 | - | 10 | - |
| Q1 2022 | - | 9 | - |
| Q4 2021 | - | 26 | - |
| Q3 2021 | - | - | - |
| Q2 2021 | 3 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 12 open market sell trades of Recursion Pharmaceuticals's stocks.
Recursion Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| SANA | Sana Biotechnology, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| CNSP | CNS Pharmaceuticals, Inc. |
| CWBR | CohBar, Inc. |
| VECT | VectivBio Holding AG |
| DAWN | Day One Biopharmaceuticals, Inc. |
| RLAY | Relay Therapeutics, Inc. |
| ABSI | Absci Corporation |
| AVRO | AVROBIO, Inc. |
| INZY | Inozyme Pharma, Inc. |
| AFMD | Affimed N.V. |
| EFTR | eFFECTOR Therapeutics, Inc. |
| IMMX | Immix Biopharma, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| OCEA | Ocean Biomedical, Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |
| ENVB | Enveric Biosciences, Inc. |
RXRX Ownership FAQ
Who Owns Recursion Pharmaceuticals?
Recursion Pharmaceuticals is owned by institutional shareholders (46.31%), insiders (4.56%), and public (49.13%). The largest institutional shareholder of Recursion Pharmaceuticals is ARK INVESTMENT MANAGEMENT LLC (11.92% of total shares) and the top mutual fund owner is Ark ETF Trust (2.68% of total shares).
Who are the major institutional shareholders of Recursion Pharmaceuticals?
Recursion Pharmaceuticals's major institutional shareholders are ARK INVESTMENT MANAGEMENT LLC, BAILLIE GIFFORD & CO, VANGUARD GROUP INC, BLACKROCK INC., and RA CAPITAL MANAGEMENT, L.P.. The top five shareholders own together 46.18% of the company's share outstanding.
How many Recursion Pharmaceuticals shareholders are there?
As of Jun 2024, there are 142 institutional shareholders of Recursion Pharmaceuticals.
What percentage of Recursion Pharmaceuticals is owned by ARK INVESTMENT MANAGEMENT LLC?
ARK INVESTMENT MANAGEMENT LLC owns 28.14M shares of Recursion Pharmaceuticals, representing 11.92% of the company's total shares outstanding, valued at $211.07M (as of Jun 2024).
What percentage of Recursion Pharmaceuticals is owned by BAILLIE GIFFORD & CO?
As of Jun 2024, BAILLIE GIFFORD & CO holds 26.59M shares of Recursion Pharmaceuticals (RXRX), compromising 11.27% of the company, valued at $199.42M.
What percentage of Recursion Pharmaceuticals is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Recursion Pharmaceuticals. The company owns 21.56M of the company's shares outstanding (worth $161.67M).